A modelling group convened by the World Health Organization and UNAIDS has estimated that if efforts are not made to mitigate and overcome interruptions in health services and supplies during the COVID-19 pandemic, a six-month disruption of antiretroviral therapy could lead to more than 500 000 extra deaths from AIDS-related …
Among peers and neighbours India is performing the worst when it comes to the health of its citizens. Whether it is life expectancy, mortality due to all causes, under-five mortality or mortality among men and women between 15 and 49 years, on most counts, India ranks way below China, Brazil …
The Delhi Government would be starting Directly Observed Treatment Short Course (DOTS) services at night shelters run by the Delhi Urban Shelter Improvement Board in a bid to ensure effective control over the incidence of tuberculosis in the city, Health Minister A.K. Walia said on Monday. The Minister said that …
As the overall prevalence of TB remains high among certain population groups, there is growing awareness of psychiatric comorbidity, especially depression and its role in the outcome of the disease. The paper attempts a holistic approach to the effects of psychiatric comorbidity to the natural history of tuberculosis. In order …
Xpert, the quick test for tuberculosis already endorsed by WHO, has been found accurate for TB including drug-resistant strains, according to a new study publsihed in The Cochrane Library. WHO in 2010 endorsed the two-hour, molecular diagnostic TB test, which requires little skilled expertise. With the cost of the test …
Some 40 drugs will soon be notified under a new schedule, H1, of Drugs and Cosmetics Act to make it mandatory for chemists to maintain a register of their sales and retain a copy of the prescription. This will be in addition to the schedule H drugs which, too, can't …
Aimed at helping school children to avoid the negative effect of irrational use of medicines, the Delhi Society for Promotion of Rational Use of Drugs (DSPRUD) in collaboration with Delhi Public School, Mathura Road, organised an awareness programme on Monday. Speaking about the programme, DSPRUD executive president Usha Gupta said: …
The disease burden saw 14 per cent increase to 31,536 cases per district during October from September’s 27,587 cases. Ninety two districts reported 2,901,262 disease incidence in the observed month compared with previous month’s 2,400,052 in 87 districts, says a Free and Fair Election (Fafen) report. The Fafen who visited …
The National Tuberculosis Centre is preparing to conduct a tuberculosis prevalence survey across the country. According to NTC Director Dr Rajendra Pant, the survey will be conducted among 55,500 randomly selected people, above the age of 15, from across the country. An NTC team will conduct interviews and chest x-rays …
JAIPUR: The United Nations (UN) Human Rights report - 2012 gives an account of the unhealthy and exploitative conditions of mine workers in the state. Published by the working group on Human Rights in India and the UN (WGHR) for India's review at UN suggests that minimal wages, poor working …
Active against drug-resistant forms, the FDA-approved drug is a game changer While there is a lot of hope and enthusiasm over the new tuberculosis drug, first in close to 50 years, health activists say the challenge for countries like India and treatment providers is devising new treatment regimens for drug-resistant …
SIALKOT - The District Health Department have detected 520 TB patients in the district. Anti-TB Programme District Coordinator Dr Nadeem Nazir disclosed this while addressing the participants of an anti-TB awareness raising workshop held here the other day. He said that the anti-TB fighting teams had established anti-TB camps at …
More than 6,000 persons in the district are in the grip of AIDS and tuberculosis (TB). As many as 3,600 cases of AIDS and 3,200 of tuberculosis (TB) have been identified in the district so far this year. Dr Baldev Singh, Medical Officer, Anti-Retroviral Therapy (ART) Centre, Civil Hospital, said: …
Publication of the Global Burden of Disease Study 2010 (GBD 2010) is a landmark event and we hope, for health. The collaboration of 486 scientists from 302 institutions in 50 countries has produced an important contribution to our understanding of present and future health priorities for countries and the global …
The programme was started at six centres in Tamil Nadu The Chennai-based National Institute for Research in Tuberculosis (formerly Tuberculosis Research Centre) has started a pilot testing programme of providing for six months isoniazid TB drug as prophylactic to HIV-positive individuals. People recruited will include those on antiretroviral therapy (ART) …
Non-communicable diseases like cancer, diabetes and heart disease killed two out of three people in 2010 — a larger share than in 1990, when they were responsible for every second death in the world. Of the 52.8 million people who died worldwide in 2010, ischaemic heart disease and stroke accounted …
High blood pressure (BP) has become the world’s deadliest diseasecausing risk factor. But for Indians, IAP (indoor air pollution) — emanating from chulhas burning wood, coal and animal dung as fuel — has been found to be a bigger health hazard for Indians. The first-ever estimate of the contribution of …
PANJIM: The quarterly meeting of TB forum of the Voluntary Health Association of Goa on Monday identified five villages where steps would be taken to create awareness about tuberculosis and help villagers to move towards elimination of the disease. The villages are Parra, Karapur-Sarvan, Pariyem-Sanquelim, Betki and Carambolim. Executive Director …
Months after the Union Health Ministry turned down demands of a section of the medical community to devise ways to fight Totally Drug Resistant (TDR) Tuberculosis, an article in the latest issue of Indian Journal of Medical Research (IJMR) has underscored the need for such a move, at least for …
Two new drugs to treat drug-resistant TB are expected to hit the market in 2013. The drugs, Bedaqiline (TMC207) and Delamanid (OPC6783) are practically the first drugs to be developed in nearly 50 years and are expected to improve treatment of DR-TB. These two investigational TB drugs are entering phase …
